Лучшие урологи по фокусированной ультразвуковой абляции (HIFU) в Польше – ТОП-2 доктора

Specializations 

Specialist in urology and general surgery Specializes in the diagnosis and treatment of prostate diseases Description The first Polish urologist certified as an Ablatherm® HIFU operator, the only doctor in Central and Eastern Europe who trains doctors and medical teams in the HIFU method. Promoter of innovative treatment methods and surgical techniques.

Professional education 

Dr. Filipek is a graduate of the Faculty of Medicine of the Medical Academy in Krakow, where he graduated from the Faculty of Medicine in 1977, in 1980 he obtained the first degree of specialization in general surgery, and in 1986 the second degree in urology. In 1999 he obtained the degree of doctor of medical sciences. 

Professional experience 

Dr. n. med. Marek Filipek serves as the Head of the Urology Department of the Independent Specialist Western Hospital in Grodzisk Mazowiecki. He created from scratch one of the most modern and best equipped urology departments in Poland. For many years, Dr. Filipek was associated with the Urology Clinic of the Jagiellonian University Medical College, where he worked as a senior assistant and lecturer. In the years 2000-2006, he was the head of the Urology Department of the St. Luke Provincial Hospital in Tarnów.

Certificates 

He participated in many scientific and advanced courses. He spent internships and scholarships in many prestigious foreign urology centers, including the Professor F. Debruyne Urology Clinic in Nijmegen. In 2014, Dr. Filipek completed training in Focal-One HIFU, with Dr. Albert Gelet, at the Hospices Civils de Lyon Edouard Herriot Hospital, in Lyon, France. In the same year, in April, the doctor also participated in the course of the European School of Urology “Focal therapy in prostate cancer” in Stockholm. 

Scientific activity

Dr. n. med. Marek Filipek is a member of the Polish Urological Society (in 1997 he was the Vice-President of the Krakow Branch of the PTU). He is also a full member of the European Urological Society. He has also been awarded many times for his scientific activity and achievements in the field of urology (winner of, among others, the 1st PTU award and the Prof. Zew Wajsman award). The scientific achievements of Dr. n. med. Marek Filipek include several dozen publications and papers presented at Polish and foreign congresses and conferences. He is the author of over 30 publications and papers published, among others, in Urologia Polska or presented at the congresses of the Polish Urological Society and the European Urological Society. He has also participated in international, multi-center clinical trials many times. Every year Dr. Filipek also participates in the meetings of the American Urological Association.

Dr. Stefan W. Czarniecki was born in the USA, where he began his education, which he continued at McGill University in Montreal and at the Jagiellonian University in Krakow. In addition to medicine, he studied art history, political science, and physics.

He runs the only comprehensive diagnostic and robotic treatment center for prostate cancer in Central Europe. He collaborates clinically with centers in the USA, the Netherlands, Great Britain, Germany, and France. Active in committees and sections of the European Association of Urology, he lectures internationally. He is the co-author of numerous scientific publications, including multi-center international analyses of the use of liquid biopsies in selective diagnostics of prostate cancer.

He specializes in oncological urology, personalized diagnostics and therapies, focal treatment, and modern active surveillance of prostate cancer. For over 10 years, he has been conducting robotic therapies in the treatment of prostate cancer using the HIFU method, and has performed >2,500 fusion biopsies of the prostate, ranking among the world's leaders. Since the beginning of his professional career, he has had a significant impact on the quality of Polish prostate cancer diagnostics and treatment as well as on media communication regarding this disease.